West to Host First-Quarter 2025 Conference Call

Rhea-AI Summary

West Pharmaceutical Services (NYSE: WST) has announced its upcoming first-quarter 2025 financial results release and conference call schedule. The company will disclose its Q1 results before market opening on Thursday, April 24, 2025, followed by a conference call at 9:00 a.m. Eastern Time to discuss financial performance and business expectations.

Interested participants must pre-register for the conference call to receive dial-in details and a unique PIN for asking questions. The event will include a live webcast and slide presentation, accessible through the Investors section of West's website. A replay of both the conference call and webcast will be available on the company website for approximately 90 days following the event.

EXTON, Pa., April 10, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter financial results before the market opens on Thursday, April 24, 2025, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.

The live webcast can be accessed by clicking here. To ask questions on the conference call, participants need to register in advance by clicking here. Registered telephone participants will receive the dial-in number along with a unique PIN number that will enable them to ask questions on the call. 

A slide presentation will be made available on the day of the call in the Investors section of the Company's website. A replay of the conference call and webcast will be available on the Company's website. Replay of the webcasts will be available for approximately 90 days after the event.

About West

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.

Headquartered in Exton, Pennsylvania, West in its fiscal year 2024 generated $2.89 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/west-to-host-first-quarter-2025-conference-call-302424869.html

SOURCE West Pharmaceutical Services, Inc.

FAQ

When will West Pharmaceutical Services (WST) release its Q1 2025 earnings?

West Pharmaceutical Services will release its Q1 2025 earnings before the market opens on Thursday, April 24, 2025.

What time is West Pharmaceutical Services' Q1 2025 earnings call?

The Q1 2025 earnings conference call is scheduled for 9:00 a.m. Eastern Time on April 24, 2025.

How can investors participate in West Pharmaceutical Services' Q1 2025 earnings call?

Investors must pre-register to receive dial-in details and a unique PIN. A live webcast will also be available through the company's website.

How long will West Pharmaceutical Services' Q1 2025 earnings call replay be available?

The conference call and webcast replay will be available on the company's website for approximately 90 days after the event.